MediciNova (MNOV) Short Interest Ratio & Short Volume $1.40 +0.03 (+1.82%) As of 05/21/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MediciNova Short Interest DataMediciNova (MNOV) has a short interest of 188,400 shares, representing 0.41% of the float (the number of shares available for trading by the public). This marks a -1.26% decrease in short interest from the previous month. The short interest ratio (days to cover) is 12.6, indicating that it would take 12.6 days of the average trading volume of 38,099 shares to cover all short positions.Current Short Interest188,400 sharesPrevious Short Interest190,800 sharesChange Vs. Previous Month-1.26%Dollar Volume Sold Short$286,368.00Short Interest Ratio12.6 Days to CoverLast Record DateApril 30, 2025Outstanding Shares49,046,000 sharesFloat Size46,480,000 sharesShort Percent of Float0.41%Today's Trading Volume16,264 sharesAverage Trading Volume38,099 sharesToday's Volume Vs. Average43% Short Selling MediciNova? Sign up to receive the latest short interest report for MediciNova and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMNOV Short Interest Over TimeMNOV Days to Cover Over TimeMNOV Percentage of Float Shorted Over Time MediciNova Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025188,400 shares $286,368.00 -1.3%0.4%12.6 $1.52 4/15/2025190,800 shares $267,120.00 -17.6%0.4%11.7 $1.40 3/31/2025231,500 shares $337,990.00 -4.1%0.5%11.5 $1.46 3/15/2025241,300 shares $374,015.00 -11.7%0.5%10.5 $1.55 2/28/2025273,400 shares $448,376.00 -9.1%0.6%9.7 $1.64 2/15/2025300,700 shares $592,379.00 -4.7%0.7%8.2 $1.97 1/31/2025315,600 shares $624,888.00 -13.6%0.7%4.3 $1.98 1/15/2025365,400 shares $683,298.00 +1.2%0.8%4.9 $1.87 12/31/2024361,100 shares $758,310.00 +4.5%0.8%5 $2.10 12/15/2024345,700 shares $725,970.00 +3.4%0.7%4.9 $2.10 Get the Latest News and Ratings for MNOV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MediciNova and its competitors with MarketBeat's FREE daily newsletter. 11/30/2024334,300 shares $692,001.00 -5.0%0.7%4.8 $2.07 11/15/2024351,800 shares $643,794.00 +93.1%0.8%4.3 $1.83 10/31/2024182,200 shares $306,096.00 -8.1%0.4%4.7 $1.68 10/15/2024198,200 shares $358,742.00 +0.7%0.4%5.2 $1.81 9/30/2024196,800 shares $413,280.00 -12.4%0.4%5.2 $2.10 9/15/2024224,600 shares $408,772.00 +19.3%0.5%5.7 $1.82 8/31/2024188,200 shares $282,300.00 +104.3%0.4%4.6 $1.50 8/15/202492,100 shares $106,836.00 -2.0%0.2%4.4 $1.16 7/31/202494,000 shares $125,960.00 -13.8%0.2%4.2 $1.34 7/15/2024109,000 shares $154,780.00 +6.0%0.2%5 $1.42 6/30/2024102,800 shares $148,032.00 -7.1%0.2%4.2 $1.44 6/15/2024110,700 shares $147,231.00 -18.4%0.2%3.2 $1.33 5/31/2024135,600 shares $184,416.00 -14.5%0.3%4.3 $1.36 5/15/2024158,600 shares $233,142.00 -25.5%0.3%4.4 $1.47 4/30/2024212,900 shares $274,641.00 -13.8%0.5%4.4 $1.29 4/15/2024247,000 shares $380,380.00 -26.0%0.5%5 $1.54 3/31/2024333,600 shares $483,720.00 +2.3%0.7%6.2 $1.45 3/15/2024326,000 shares $423,800.00 -3.5%0.7%5.6 $1.30 2/29/2024337,800 shares $456,030.00 +34.5%0.7%5.7 $1.35 2/15/2024251,200 shares $339,120.00 +3.3%0.5%4.1 $1.35 1/31/2024243,100 shares $342,771.00 -24.8%0.5%2.1 $1.41 1/15/2024323,400 shares $485,100.00 -8.3%0.7%2.8 $1.50 12/31/2023352,600 shares $528,900.00 -6.5%0.8%3.2 $1.50 12/15/2023377,100 shares $588,276.00 +0.5%0.8%3.6 $1.56 11/30/2023375,100 shares $678,931.00 +57.7%0.8%3.8 $1.81 11/15/2023237,800 shares $418,528.00 -2.3%0.5%2.5 $1.76 10/31/2023243,400 shares $464,894.00 -20.7%0.5%11.6 $1.91 10/15/2023307,000 shares $614,000.00 -16.1%0.7%14.3 $2.00 9/30/2023365,700 shares $764,313.00 -1.8%0.8%17.3 $2.09 9/15/2023372,400 shares $759,696.00 +0.8%0.8%19.8 $2.04Trump’s treachery (Ad)I think Trump’s Treasury Secretary is destroying the stock market on purpose. And no one on Wall Street seems to understand why. Like an addict who needs desperate help, Trump’s Treasury pick, Scott Bessent, is putting America through a “detox period” — and I think it’s going to be absolutely brutal for our economy. Why’s he doing this?You may have already noticed the effect on your portfolio as markets have begun to bleed. 8/31/2023369,500 shares $901,580.00 +0.4%0.8%18.1 $2.44 8/15/2023368,100 shares $850,311.00 -0.3%0.8%18.9 $2.31 7/31/2023369,300 shares $878,934.00 -2.1%0.8%20.6 $2.38 7/15/2023377,300 shares $965,888.00 +0.7%0.8%20.6 $2.56 6/30/2023374,800 shares $862,040.00 +5.6%0.8%18.3 $2.30 6/15/2023354,800 shares $819,588.00 +4.7%0.8%18.1 $2.31 5/31/2023339,000 shares $728,850.00 -4.6%0.7%17.6 $2.15 5/15/2023355,400 shares $783,657.00 +1.6%0.8%17.9 $2.21 4/30/2023349,700 shares $737,867.00 -0.6%0.8%16.7 $2.11 4/15/2023351,800 shares $809,140.00 +3.9%0.8%16.4 $2.30 3/31/2023338,700 shares $731,592.00 -1.1%0.7%13.3 $2.16 3/15/2023342,600 shares $719,460.00 -5.4%0.7%7.5 $2.10 2/28/2023362,100 shares $796,620.00 -0.2%0.8%5.4 $2.20 2/15/2023362,800 shares $838,068.00 -3.1%0.8%4.9 $2.31 1/31/2023374,500 shares $895,055.00 -0.9%0.8%4.7 $2.39 1/15/2023377,800 shares $936,944.00 -3.8%0.8%4.6 $2.48 12/30/2022392,700 shares $805,035.00 -25.7%0.9%4.8 $2.05 12/15/2022528,700 shares $1.24 million +20.9%1.1%7.4 $2.35 11/30/2022437,200 shares $1.15 million -34.7%0.9%10.1 $2.64 11/15/2022669,300 shares $1.44 million -17.6%1.4%18.5 $2.15 10/31/2022812,400 shares $1.66 million +0.1%1.8%26.9 $2.04 10/15/2022811,600 shares $1.62 million -15.6%1.8%30.2 $1.99 9/30/2022961,000 shares $2.09 million -11.8%2.1%36 $2.17 9/15/20221,090,000 shares $2.40 million -3.5%2.4%45.4 $2.20 8/31/20221,130,000 shares $2.41 million -1.7%2.4%48.3 $2.13 8/15/20221,150,000 shares $2.85 million No Change2.5%45.6 $2.48 7/31/20221,150,000 shares $2.66 million -4.2%2.4%42.6 $2.31 7/15/20221,200,000 shares $2.86 million -0.8%2.5%41.4 $2.38 6/30/20221,210,000 shares $3.06 million -2.4%2.5%34 $2.53 6/15/20221,240,000 shares $3.16 million -0.8%3.5%28.8 $2.55 5/31/20221,250,000 shares $3.04 million +0.8%2.7%28.3 $2.43 5/15/20221,240,000 shares $2.99 million -7.5%2.7%26.1 $2.41 4/30/20221,340,000 shares $3.58 million -3.6%2.9%26.3 $2.67 4/15/20221,390,000 shares $4.25 million -4.1%3.0%14.6 $3.06 3/31/20221,450,000 shares $3.87 million No Change3.1%14.3 $2.67 3/15/20221,450,000 shares $3.34 million -13.7%3.1%12.3 $2.30 2/28/20221,680,000 shares $4.02 million -2.9%3.6%10.7 $2.39 2/15/20221,730,000 shares $4.26 million +10.9%3.7%3.2 $2.46 1/31/20221,560,000 shares $3.78 million -12.4%3.4%2.9 $2.42 1/15/20221,780,000 shares $4.49 million -1.1%3.8%3.5 $2.52 12/31/20211,800,000 shares $4.82 million -4.8%3.9%3.6 $2.68 12/15/20211,890,000 shares $5.42 million -17.5%4.1%3.8 $2.87 11/30/20212,290,000 shares $7.51 million +30.1%4.9%4.9 $3.28 11/15/20211,760,000 shares $6.21 million +2.9%3.8%4.1 $3.53 10/29/20211,710,000 shares $5.75 million +0.6%3.7%14.3 $3.36 10/15/20211,700,000 shares $6.49 million -1.7%3.7%13.9 $3.82 9/30/20211,730,000 shares $6.56 million -9.0%3.7%10.8 $3.79 9/15/20211,900,000 shares $7.58 million -0.5%4.1%5.7 $3.99 8/31/20211,910,000 shares $7.47 million -5.9%4.1%2.3 $3.91 8/13/20212,030,000 shares $7.13 million -1.9%4.4%2.4 $3.51AI Bloodbath Coming on June 1st? (Ad)If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.Click here to see the details and learn how to prepare for the next AI revolution 7/30/20212,070,000 shares $7.51 million -2.8%4.5%2.5 $3.63 7/15/20212,130,000 shares $7.88 million -9.8%4.6%2.4 $3.70 6/30/20212,360,000 shares $10.03 million -40.1%5.1%2.6 $4.25 6/15/20213,940,000 shares $16.15 million +1.0%8.5%5 $4.10 5/28/20213,900,000 shares $16.46 million -0.5%8.4%8.3 $4.22 5/14/20213,920,000 shares $15.88 million +6.2%N/A4.2 $4.05 4/30/20213,690,000 shares $17.42 million +17.9%N/A4 $4.72 4/15/20213,130,000 shares $14.49 million +1.6%N/A3.5 $4.63 3/31/20213,080,000 shares $15.25 million -2.2%N/A3.5 $4.95 3/15/20213,150,000 shares $18.99 million +36.4%N/A3.6 $6.03 2/26/20212,310,000 shares $12.57 million +3.1%N/A10.4 $5.44 2/12/20212,240,000 shares $14.29 million -17.7%N/A11.1 $6.38 1/29/20212,720,000 shares $15.83 million -2.2%6.7%12.9 $5.82 1/15/20212,780,000 shares $15.90 million -4.1%6.9%13.3 $5.72 12/31/20202,900,000 shares $14.99 million +12.8%7.2%15.3 $5.17 12/15/20202,570,000 shares $15.42 million -7.9%6.4%11.5 $6.00 11/30/20202,790,000 shares $16.66 million -15.2%6.9%6 $5.97 11/15/20203,290,000 shares $19.87 million +2.2%8.2%7 $6.04 10/30/20203,220,000 shares $18.39 million +2.9%8.0%6.7 $5.71 10/15/20203,130,000 shares $16.46 million -7.7%7.9%1.6 $5.26 9/30/20203,390,000 shares $17.76 million +42.4%8.5%1.7 $5.24 9/15/20202,380,000 shares $13.85 million +3.9%6.1%1.2 $5.82 8/31/20202,290,000 shares $12.00 million -2.6%5.9%1.4 $5.24 8/14/20202,350,000 shares $14.24 million -19.2%6.3%1.5 $6.06 7/31/20202,910,000 shares $18.10 million +21.8%7.8%1.8 $6.22 7/15/20202,390,000 shares $12.74 million +3.5%6.5%18.5 $5.33 6/30/20202,310,000 shares $12.57 million +6.9%6.2%13.1 $5.44 6/15/20202,160,000 shares $13.74 million -4.9%5.8%13.3 $6.36 5/29/20202,270,000 shares $12.12 million +1.8%6.1%12.6 $5.34 MNOV Short Interest - Frequently Asked Questions What is MediciNova's current short interest? Short interest is the volume of MediciNova shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 188,400 shares of MNOV short. 0.41% of MediciNova's shares are currently sold short. Learn More on MediciNova's current short interest. What is a good short interest ratio for MediciNova? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MNOV shares currently have a short interest ratio of 13.0. Learn More on MediciNova's short interest ratio. What is a good short interest percentage for MediciNova? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.41% of MediciNova's floating shares are currently sold short. Is MediciNova's short interest increasing or decreasing? MediciNova saw a drop in short interest in April. As of April 30th, there was short interest totaling 188,400 shares, a drop of 1.3% from the previous total of 190,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is MediciNova's float size? MediciNova currently has issued a total of 49,046,000 shares. Some of MediciNova's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. MediciNova currently has a public float of 46,480,000 shares. How does MediciNova's short interest compare to its competitors? 0.41% of MediciNova's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to MediciNova: Aurora Cannabis Inc. (9.46%), Aquestive Therapeutics, Inc. (9.47%), Compass Therapeutics, Inc. (8.69%), DBV Technologies S.A. (0.59%), Corvus Pharmaceuticals, Inc. (8.46%), Immutep Limited (2.78%), Cartesian Therapeutics, Inc. (30.19%), Aura Biosciences, Inc. (4.83%), Canopy Growth Co. (10.08%), 2seventy bio, Inc. (5.37%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short MediciNova stock? Short selling MNOV is an investing strategy that aims to generate trading profit from MediciNova as its price is falling. MNOV shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against MediciNova? A short squeeze for MediciNova occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MNOV, which in turn drives the price of the stock up even further. How often is MediciNova's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MNOV, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Aurora Cannabis Short Interest Data Aquestive Therapeutics Short Interest Data Compass Therapeutics Short Interest Data DBV Technologies Short Interest Data Corvus Pharmaceuticals Short Interest Data Immutep Short Interest Data Cartesian Therapeutics Short Interest Data Aura Biosciences Short Interest Data Canopy Growth Short Interest Data 2seventy bio Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MNOV) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediciNova, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediciNova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
